Gene · 10747
Papers2,026
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
21 to 40 of 2,026
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Proteomic profiling of circulating extracellular vesicles from COVID-19 patients and their impact on innate Vdelta2 T-cell response. | Front Immunol | 2026 | 41756302 | PubTator, text mining | PubMed |
| Small Molecule Activator of Phosphatase PP2A Remodels Scaffold PR65 Structural Dynamics To Promote Holoenzyme Assembly. | JACS Au | 2026 | 41755833 | PubTator, text mining | PubMed |
| Advances in the lectin pathway in systemic lupus erythematosus: from clinical correlations and mechanisms to targeted interventions. | Inflamm Res | 2026 | 41741777 | PubTator, text mining | PubMed |
| Proteomics profiling of serum and liver in GSD Ia and Ib patients: insights into complication mechanisms and circulation biomarkers. | J Transl Med | 2026 | 41721410 | PubTator, text mining | PubMed |
| Complement C3 recognition by C3 convertases. | Sci Adv | 2026 | 41719406 | PubTator, text mining | PubMed |
| Characterization of the Complement Cascade in Human Traumatic Brain Injury. | J Neurotrauma | 2026 | 41700694 | PubTator, text mining | PubMed |
| Transcriptional and epigenetic regulation of Ca2+-signaling genes in hepatitis B-derived hepatocellular carcinoma and their association with the cancer hallmarks. | Bioinform Adv | 2026 | 41640621 | PubTator, text mining | PubMed |
| The Role of MASP1, MASP2, and Mannose-Binding Lectin in the Immune Response to Hepatitis B Vaccination in Infants. | Vaccines (Basel) | 2026 | 41601013 | PubTator, text mining | PubMed |
| The Structural Analogy of MASP-2 with Thrombin and MASP-1 Reveals Strong Binding with PAR4. | Antiinflamm Antiallergy Agents Med Chem | 2026 | 41588767 | PubTator, text mining | PubMed |
| Activation of the Lectin Pathway Drives Persistent Complement Dysregulation in Long COVID. | Immunology | 2026 | 41581925 | PubTator, text mining | PubMed |
| Integrated transcriptomic and metabolomic analyses reveal the molecular adaptive mechanisms of Schizopygopsis chengi baoxingensis under acute heat stress. | J Therm Biol | 2026 | 41581381 | PubTator, text mining | PubMed |
| Use of narsoplimab for eculizumab-refractory adult transplant-associated thrombotic microangiopathy (TA-TMA). | Ann Hematol | 2026 | 41545744 | PubTator, text mining | PubMed |
| Urinary extracellular vesicle proteins for biomarker discovery in chronic kidney disease. | Kidney Res Clin Pract | 2026 | 41532152 | PubTator, text mining | PubMed |
| Targeting the lectin pathway in TA-TMA. | Blood Adv | 2026 | 41481340 | PubTator, text mining | PubMed |
| Mass Spectrometry Proteomics: A Key to Faster Drug Discovery. | J Med Chem | 2026 | 41433248 | PubTator, text mining | PubMed |
| Serial proteomic analysis identifies small extracellular vesicle-MASP2 as an early biomarker of chemotherapy response in advanced pancreatic cancer. | Transl Oncol | 2026 | 41389674 | PubTator, text mining | PubMed |
| Differential expression of complement Properdin and Factor H in the placentae and umbilical cords of mothers with Preeclampsia, Gestational Diabetes Mellitus and Recurrent Pregnancy Loss. | Front Immunol | 2025 | 41710025 | PubTator, text mining | PubMed |
| Characterization of a Long-Acting Anti-Human MASP-2 Antibody for the Treatment of Complement-Related Diseases. | J Inflamm Res | 2025 | 41293649 | PubTator, text mining | PubMed |
| Alternative pathway-mediated tubular complement activation in human proteinuric kidney diseases: a proof-of-concept study. | Clin Kidney J | 2025 | 41215783 | PubTator, text mining | PubMed |
| Triangle weaver spiders construct spring-loaded webs using a novel set of genes for exceptionally proline-rich silk. | PNAS Nexus | 2025 | 41200101 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/10747/papers?page=2